BrainQ Non-Invasive BCI

AI-powered non-invasive electromagnetic neurorecovery device for stroke rehabilitation. It is a biometric system designed for physical AI applications. Key specifications include Form Factor: biometric, Maturity: pilot.

Yes. BrainQ Non-Invasive BCI is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

BrainQ Non-Invasive BCI is made by BrainQ, based in Israel.

3 verified deployments of BrainQ Non-Invasive BCI are on the DEPLOY registry, including at White Plains, New York, USA, Miami, Florida, USA, Washington, DC, USA.

BrainQ Non-Invasive BCI is in pilot deployments with named customers and is not yet broadly for sale.

On the DEPLOY registry, comparable biometric robots to BrainQ Non-Invasive BCI include Blackrock Neuroport Array, Neko Body Scan, RNS System, Amazfit (Balance / Active / T-Rex / Helio).

BrainQ Non-Invasive BCI and Blackrock Neuroport Array (Blackrock Neurotech · 5 deployments) are both biometric robots on the DEPLOY registry. BrainQ Non-Invasive BCI has 3 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, BrainQ Non-Invasive BCI ranks in roughly the top 7% of biometric models tracked by the registry.

BrainQ Non-Invasive BCI is at the pilot stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Pilot stage means at least one named-customer trial deployment is verified.

BrainQ Non-Invasive BCI has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.